NCT05545085 - Thoracoscopic Laser Speckle Contrast Imaging for Segment Resections | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

April 1, 2023

Study Completion Date

September 1, 2023

Conditions

Pulmonary Cancer

Interventions

DEVICE

Laser Speckle Contrast Imaging using the PerfusiX-Imaging Device

Patient will undergo the standard of care lobectomy for pulmonary cancer. In addition, peroperative imaging using the Laser Speckle Contrast Imaging device will be performed.

Trial Locations (1)

8934 AD

RECRUITING

Medical Center Leeuwarden, Leeuwarden